Discover 1,187 paid clinical trials in Dayton, Ohio. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,187
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
for
Head and Neck Squamous Cell Carcinoma (HNSCC)
Location: Edgewood KY, Columbus OH, Louisville KY, Detroit MI,
Sponsor: Regeneron Pharmaceuticals
Sex: All
Age: 18+
Code: NCT06769698
Phase 2, Recruiting
A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer
for
Pancreatic Cancer, Metastatic Pancreatic Cancer,
Location: Edgewood KY, Columbus OH, Indianapolis IN, Ann Arbor MI,
Sponsor: Astellas Pharma Global Development, Inc.
Sex: All
Age: 18+
Code: NCT07409272
Phase 3, Recruiting
A Phase 1 Study of LNCB74 in Advanced Solid Tumors
for
Ovarian Cancer, Breast Cancer, Endometrial Cancer,
Location: Edgewood KY, Cleveland OH, Pittsburgh PA, St Louis MO,
Sponsor: NextCure, Inc.
Sex: All
Age: 18+
Code: NCT06774963
Phase 1, Recruiting
IMC-F106C Regimen Versus Nivolumab Regimens in Previously Untreated Advanced Melanoma (PRISM-MEL-301)
for
Advanced Melanoma
Location: Edgewood KY, Columbus OH, Detroit MI, Pittsburgh PA,
Sponsor: Immunocore Ltd
Sex: All
Age: 18+
Code: NCT06112314
Phase 3, Recruiting
EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)
for
Breast Cancer
Location: Edgewood KY, Louisville KY, Canton OH, Cleveland OH,
Sponsor: Exact Sciences Corporation
Sex: All
Age: 18+
Code: NCT06401421
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn's Disease
Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Sex: Female
Age: 40 - 60
Code: NCT06856174
Recruiting
A Study to Investigate PORT-77 Oral Dosing Compared With Placebo in Participants With Erythropoietic Protoporphyria (EPP) or X-linked Protoporphyria (XLP)
for
Erythropoietic Protoporphyria (EPP),
Location: Cincinnati OH, Huntington Beach CA
Sponsor: Portal Therapeutics, Inc.
Sex: All
Age: 12+
Code: NCT07820085
Phase 2, Phase 3, Recruiting
Evaluation of Efficacy and Safety of Iloperidone for the Treatment of Participants With Uncontrolled Hypertension
for
Hypertension, Uncontrolled Hypertension
Location: Cincinnati OH, Lexington KY, Tinley Park IL,
Sponsor: Vanda Pharmaceuticals
Sex: All
Age: 18 - 65
Code: NCT07090161
Phase 2, Recruiting
Patient Retrospective Outcomes (PRO)
for
Chronic Pain
Location: Cincinnati OH, New Castle IN, Muncie IN, Toledo OH,
Sponsor: Boston Scientific Corporation
Sex: All
Age: 18+
Code: NCT01550575
Recruiting
Fabry Disease Registry & Pregnancy Sub-registry
for
Fabry Disease
Location: Cincinnati OH, Dublin OH, Columbus OH, Indianapolis IN,
Sponsor: Genzyme, a Sanofi Company
Sex: All
Age: 0+
Code: NCT00196742
Recruiting
Optimizing Beta Blocker Dosage in Women While Using the Wearable Cardioverter Defibrillator
for
Cardiomyopathies, Heart Failure
Location: Cincinnati OH, McKinney TX
Sponsor: Zoll Medical Corporation
Sex: Female
Age: 18+
Code: NCT04504188
Recruiting
Tempus Small Cell Lung Cancer Observational Study (Sculptor)
for
Small Cell Lung Cancer
Location: Cincinnati OH, Columbus OH, Peoria IL, Chapel Hill NC,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05257551
Recruiting
GEMINI-NSCLC: NSCLC Biomarker Study
for
Non-Small Cell Lung Cancer
Location: Cincinnati OH, Columbus OH, Indianapolis IN, Maumee OH,
Sponsor: Tempus AI
Sex: All
Age: 18+
Code: NCT05236114
Recruiting
Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)